Prof. Javed Iqbal

Prof. Javed Iqbal Founder and Chairman

Education
  • Ph.D. Chemistry, Delhi University
  • Post-Doctoral, Oxford University
Special Interests
  • Drug discovery and development
  • Organic chemistry
  • Entrepreneurship

Prof. Javed Iqbal earned his Ph.D. in Chemistry in 1977 from Delhi University, following which he worked in the area of organo‐silicon chemistry as an SERC post‐doctoral fellow in the group of Prof. Ian Fleming at Cambridge University. Subsequently he moved to Oxford University as a post‐doctoral fellow with Prof. Sir J.E. Baldwin and worked on penicillin biosynthesis, and then with Prof. R.J.P. Coreau as a visiting fellow at the University of Montpellier, France. After teaching for a year at the University of Montpellier, he returned to India in 1984 and joined the faculty of the Indian Institute of Technology, Kanpur in the department of chemistry and became a professor there in 1990. He has also served as Director of the Regional Research Laboratory (CSIR), Trivandrum and as visiting professor at the University of Notre Dame, USA and the University of Okayama, Japan, and has taught chemistry at the New Mexico State University, USA.

In the year 2000, he switched to industry, and moved to Dr. Reddy\’s Laboratories Ltd. (DRL) where he served as Distinguished Research Scientist and Head of Discovery Chemistry until 2007. He headed a research group of 140 scientists at DRL’s Hyderabad and Atlanta discovery research facilities. His discovery chemistry group at DRL was responsible for designing and synthesizing small molecules for therapeutic targets like Peroxisome Proliferator‐Activated Receptor, AMP‐activated kinase, MAP, Aurora and Jun kinases, Cannabinoid receptor B1, Cholesteryl Ester transfer protein and on targets responsible for lipoic acid synthesis and Perlecan induction. In addition, his group was extensively involved in the synthesis of antibacterials based on oxazolidinone and tetracycline scaffolds. Two of the drugs discovered by his group are undergoing clinical trials in Canada and the UK. He has pioneered research work on AMP Kinase as therapeutic target for treating diabetes and obesity and is the co‐inventor of an AMP Kinase activator which is currently undergoing clinical trials. He has published more than 200 research papers and has filed 45 patents in his area of research. He has mentored a number of research students including 25 doctoral students.

Prof. Iqbal is a fellow of the Indian Academy of Sciences (INSA), Bangalore and Indian National Sciences Academy, New Delhi. He served as a Council Member of INSA (2003‐05) and as member of the IUPAC committee on Chemistry and Drugs (2006‐09). He was conferred the Vigyan Gaurav Award by the Uttar Pradesh Government in 2006. He has also served as member of the International Advisory Committee of the journal Chem. Med. Chem. published by Wiley. He is a member of the New York Academy of Sciences and the American Chemical Society. He served as founder Director of Dr. Reddy’s Institute of Life Sciences in Hyderabad between 2007-2014.

Our Mission

Provide contract business development and innovation advisory services to biotechnology and pharmaceutical companies working in the discovery and development of therapeutics through one of the largest networks of labs and experts.

How can we help you?

Contact us today to find out more info.

416-123-4567

Looking for a pharmaceutical discovery & development company?